Ty Howton

Ty Howton, J.D. is currently serving as AavantiBio’s Chief Operating Officer and General Counsel. Mr. Howton was previously at Sarepta Therapeutics, where he had served as their Executive Vice President, General Counsel, and Corporate Secretary since November 2012. In his role at Sarepta, Mr. Howton also oversaw quality assurance, information technology, and compliance.

Preceding his role at Sarepta, Mr. Howton served as Senior Vice President, Chief Legal Officer, and a member of the executive team at Vertex Pharmaceuticals. In this capacity, he participated in the general management of the company and oversaw all aspects of the Vertex global legal and compliance departments. He previously served as Chief Compliance Officer at Vertex, where he was responsible for designing and implementing the Vertex corporate compliance program as well as chairing the company’s corporate compliance committee.

Before joining Vertex, Mr. Howton worked at Genentech, a biotechnology company, where he served in several legal roles before becoming the company’s Chief Healthcare Compliance Officer. Mr. Howton was formerly a member of the Sidley Austin corporate healthcare practice, where he advised on corporate transactions involving life science companies and provided regulatory counsel.

Mr. Howton holds a BA from Yale University and a JD from Northwestern University School of Law.